Development of In Vitro Diagnostics for Biodefense, Antimicrobial Resistant Infections(AMR), and Emerging Infectious Diseases

$42.12M USD

Funder	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Recipient Organization	Ge Medical Systems Information Technologies, Inc
Country	United States
Start Date	Sep 18, 2024
End Date	Sep 17, 2029
Duration	1,825 days
Number of Grantees	1
Roles	Principal Investigator
Data Source	NIH (US)
Grant ID	`11196801`

Grant Description

To support the development of promising diagnostics technologies for biothreat pathogens and toxins, as well as pathogens causing emerging and reemerging infectious diseases.

Areas of support may focus on improving performance of agnostic nucleic acid sequencing solutions on commercial platforms; methods that improve protein analyte detection; and efforts to improve direct-from-blood or other biofluid detection and identification of microbial infection.